Search Results - "Tomášková, Veronika"

  • Showing 1 - 5 results of 5
Refine Results
  1. 1

    Human myeloid‐derived suppressor cell expansion during sepsis is revealed by unsupervised clustering of flow cytometric data by De Zuani, Marco, Hortová‐Kohoutková, Marcela, Andrejčinová, Ivana, Tomášková, Veronika, Šrámek, Vladimír, Helán, Martin, Frič, Jan

    Published in European journal of immunology (01-07-2021)
    “…Myeloid‐derived suppressor cells (MDSCs) are important regulators of immune processes during sepsis in mice. However, confirming these observations in humans…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Differences in monocyte subsets are associated with short‐term survival in patients with septic shock by Hortová‐Kohoutková, Marcela, Lázničková, Petra, Bendíčková, Kamila, De Zuani, Marco, Andrejčinová, Ivana, Tomášková, Veronika, Suk, Pavel, Šrámek, Vladimír, Helán, Martin, Frič, Jan

    Published in Journal of cellular and molecular medicine (01-11-2020)
    “…Sepsis is characterized by dynamic changes of the immune system resulting in deregulated inflammation and failure of homoeostasis and can escalate to septic…”
    Get full text
    Journal Article
  4. 4

    Prognostic value of soluble endoglin in patients with septic shock and severe COVID-19 by Tomášková, Veronika, Mýtniková, Alexandra, Hortová Kohoutková, Marcela, Mrkva, Ondřej, Skotáková, Monika, Šitina, Michal, Helánová, Kateřina, Frič, Jan, Pařenica, Jiří, Šrámek, Vladimír, Helán, Martin

    Published in Frontiers in medicine (31-08-2022)
    “…Sepsis is a clinical syndrome characterized by a dysregulated response to infection. It represents a leading cause of mortality in ICU patients worldwide…”
    Get full text
    Journal Article
  5. 5

    High CD4‐to‐CD8 ratio identifies an at‐risk population susceptible to lethal COVID‐19 by De Zuani, Marco, Lazničková, Petra, Tomašková, Veronika, Dvončová, Martina, Forte, Giancarlo, Stokin, Gorazd Bernard, Šrámek, Vladimir, Helán, Martin, Frič, Jan

    Published in Scandinavian journal of immunology (01-03-2022)
    “…Around half of people with severe COVID‐19 requiring intensive care unit (ICU) treatment will survive, but it is unclear how the immune response to SARS‐CoV‐2…”
    Get full text
    Journal Article